Migrants who arrived in Denmark before the age of 15 had a risk of
multiple sclerosis that was higher than that in their country of birth, although lower than that among ethnic Danes.
The approval was based on data from the phase III Expand randomised, double-blind and placebo-controlled study designed to compare the efficacy and safety of Mayzent against placebo in people living with secondary progressive
multiple sclerosis.
For information about the National
Multiple Sclerosis Society, Greater Illinois Chapter, visit www.nationalmssociety.org/Chapters/ILD, or www.facebook.com/MSGreaterIL.
Overview of
multiple sclerosis and nursing care of the M.S.
Leveraging these strengths, we hope to maximize the benefits for
multiple sclerosis patients and their families."
Subjects and Methods: A cross-sectional study was carried out in a tertiary care hospital of Karachi where a total of 85 patients of
multiple sclerosis were interviewed using a structured questionnaire from June to November, 2014.
Keywords:
Multiple sclerosis, Pediatric, Magnetic Resonance Imaging.
Multiple sclerosis is a disease in which the immune system eats away at the protective covering of nerves.
Multiple sclerosis predominantly affects women (2:1) with an incidence rate in New Zealand of 73.1/100,000 population.
Myokymia, with or without progression to facial intermittent spasm, and with or without sustained contractures, is said in the literature to be an uncommon presentation of
multiple sclerosis. It can sometimes be seen during a relapse [2].
Subjects in the current investigation were derived from a study in Sweden in which 1,620 patients with
multiple sclerosis were matched for age and other factors with 2,788 control subjects, and a study in the US that matched 1,159
multiple sclerosis patients with 1,172 controls.
According to researchers,
multiple Sclerosis is a chronic progressive auto-immune disease in which the body's own immune system attacks the nervous tissue, potentially resulting in movement disorders, Health news reported.
The past several years have produced significant progress in the clinical understanding and treatment of
multiple sclerosis (MS).
In a cross-sectional study of 264 patients with
multiple sclerosis (mean age, 47 years; mean disease duration, 14.6 years) and 69 healthy controls, increased summer sun exposure during the preceding 2 years was associated with increased brain gray matter volume (p < 0.02) and increased whole brain volume (p = 0.004), after adjusting for disability and serum 25-hydroxyvitamin D levels.
